Loading...

TNDM TANDEM DIABETES CARE INC Management Changes 8-K Filing

TNDM

TNDM

TANDEM DIABETES CARE INC

(TNDM)

2026 8-K

Management Change

Financial Results Update

Note Offering Announcement

Quarterly Financial Results

Bylaw Amendments

Board Appointment

Financial Results Announced

New Product Launches

Financial Statements

Settlement Agreement

Market Expansion

New Product Launches

Financial Statements

Financial Results

Financial Results

Earnings Reports

Appointment of Jean-Claude ...

Agreements with Dexcom

Annual Meeting of Stockholders

Agreement Extension and Pro...

Earnings Reports

FDA Clearance for Tandem Mo...

Private Offering of Convert...

Earnings Reports

Departure of Directors or C...

Departure of Directors

Other Special Situation

Earnings Reports

Resignation of Executive

Financial Results for Q2 2023

Annual Meeting of Stockholders

Earnings Reports

Financial Results and Board...

Completion of Acquisition

Financial Results Announcement

External Links:

On May 11, 2026, Tandem Diabetes Care announced the termination of Mark Novara, their Executive Vice President and Chief Commercial Officer, effective May 18, 2026; however, the company's strategy and goals for 2026 remain unchanged.

AI Assistant

TANDEM DIABETES CARE INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.